bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Citius Pharmaceuticals Inc. logo

    Citius Pharmaceuticals Inc.

    CTXR | NASDAQ
    Chart Builder DCF Calculator
    $0.58
    $0 (+0.61%)
    Sep 22, 2026, 11:23 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $6.44M
    Enterprise Value
    $-3.39M
    Beta
    1.00
    Average Volume
    625K
    Shares Outstanding (Diluted)
    26.17M
    Shares Change YoY
    137.76%
    Institutional Ownership
    4.46%
    Exchange
    NASDAQ
    ISIN
    US17322U3068

    Price Performance

    Price Change 1M
    -4.9%
    Price Change 3M
    3.6%
    Price Change 6M
    -19.4%
    Price Change YTD
    -31.6%
    Price Change 1Y
    -50.0%
    Price Change 3Y
    -96.7%
    Price Change 5Y
    -98.9%
    1M CAGR (ann.)
    -15.5%
    1Y CAGR (ann.)
    -50.7%
    5Y CAGR (ann.)
    -59.4%
    All-Time CAGR
    -41.8%

    Valuation

    PE Ratio
    -0.27
    Forward PE
    0.65
    PEG Ratio
    -0.00
    Forward PEG
    0.01
    PS Ratio
    0.91
    Forward PS
    0.30
    PB Ratio
    0.10
    P/FCF Ratio
    -0.20
    P/Adj. FCF Ratio
    -0.14
    P/OCF Ratio
    -0.44
    EV/Sales
    -0.48
    EV/EBIT
    0.07
    EV/EBITDA
    0.06
    EV/FCF
    0.11
    Earnings Yield
    -363.8%
    FCF Yield
    -490.5%
    Adj. FCF Yield
    -702.8%

    Financial Health

    Net Cash
    $9.83M
    Total Debt
    $7.18M
    Cash & Short-Term Investments
    $17.01M
    Total Assets
    $142.26M
    Current Ratio
    0.84
    Quick Ratio
    0.40
    Debt / Equity Ratio
    0.11
    Debt / EBITDA
    -0.12
    Debt / FCF
    -0.23
    OCF / Debt
    -4.40
    Interest Coverage
    -88.28
    Altman Z-Score
    -3.84
    Piotroski F-Score
    4

    Margins & Profitability

    Gross Profit Margin
    20.0%
    Operating Profit Margin
    -857.0%
    EBITDA Margin
    -804.6%
    Net Profit Margin
    -651.3%
    FCF Margin
    -444.7%
    Adj. FCF Margin
    -637.2%
    SBC / Revenue
    154.2%
    SBC Impact (per share)
    -43.3%

    Returns

    Return on Assets
    -32.5%
    Return on Equity
    -67.2%
    Return on Invested Capital
    -67.6%
    Return on Capital Employed
    -67.8%
    Return on Tangible Assets
    -104.9%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    146.8%
    Revenue CAGR 5Y
    98.9%
    Revenue CAGR 10Y
    54.3%
    EPS CAGR 3Y
    29.9%
    EPS CAGR 5Y
    -36.0%
    EPS CAGR 10Y
    -13.9%
    FCF CAGR 3Y
    -2.3%
    FCF CAGR 5Y
    19.6%
    FCF CAGR 10Y
    -11.9%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    1
    EPS Growth Next 3Y
    31.8%
    Revenue Growth Next 3Y
    119.0%
    Earnings Date
    Dec 16, 2026
    EPS Estimate (next Q)
    -$0.41
    EPS Growth Est (next Q)
    4000.0%
    Revenue Est (next Q)
    $2.95M
    Revenue Growth Est (next Q)
    -25.3%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $6
    Price Target Upside
    934.5%

    Cash Flow

    Operating Cash Flow
    $-31.6M
    Free Cash Flow
    $-31.6M
    Adj. Free Cash Flow
    $-45.27M
    FCF Per Share
    -$1.33
    OCF Per Share
    -$1.33
    OCF/S Ratio
    -490.7%

    Income Statement

    Revenue
    $7.11M
    Gross Profit
    $3.14M
    Operating Income
    $-60.89M
    EBITDA
    $-58.44M
    Net Income
    $-49.33M
    EPS (Diluted)
    -$2.11
    Revenue / Employee
    $308.92K
    Profit / Employee
    $-2.14M
    Employees
    23

    © 2026 bestshares.com. All rights reserved.